Eribulin - BSG
British Sarcoma Group
Executive Office 35 Sandford Avenue Church Stretton Shropshire SY6 6BH Telephone 01694 722123
Soft Tissue Sarcoma - Adult
| Trial Name | Eribulin in 3rd line for soft tissue sarcoma |
| Description | Phase III prospective randomised controlled trial of comparing the efficacy and safety of eribulin with dacarbazine in patients with advanced soft tissue sarcoma who have disease progression within 6 months prior to study enrolment following standard therapies which must have included an anthracycline, unless contraindicated and at least one additional regimen. after failure of the anthracycline. |
| Reference | NCT01327885 NCRN portfolio Sponsor: Eisai |
| Status / Sites | OPEN London, Manchester, Glasgow, Swansea |
| UK Chief Investigator Contact | Dr Mike Leahy, Manchester |
Soft Tissue Sarcoma - ADULT
Soft Tissue Sarcoma - PAEDIATRIC
Bone Sarcoma
GIST
You are viewing the text version of this site.
To view the full version please install the Adobe Flash Player and ensure your web browser has JavaScript enabled.
Need help? check the requirements page.
